中国生物制药宣布收购拉诺瓦医药95.09%股权

华尔街洞察
Jul 15, 2025

中国生物制药披露了其收购拉诺瓦医药95.09%股权的计划。此次交易将通过其全资子公司正大制药投资(北京)集团有限公司执行。买卖协议已于2025年7月15日正式签署,明确了具体条款和条件。拉诺瓦医药的股东已同意出售其股权。不过,交易最终完成还需满足特定条件。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10